|
|
|
Insider
Information: |
Smiley Joshua L |
Relationship: |
|
City: |
Indianapolis |
State: |
IN |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
2 |
|
Direct
Shares |
109,343 |
|
Indirect Shares
|
2,151 |
|
|
Direct
Value |
$68,811,723 |
|
|
Indirect Value
|
$1,889,546 |
|
|
Total
Shares |
111,494 |
|
|
Total
Value |
$70,701,268 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
1
|
Stock
price went up :
|
0
|
1
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
1.0
|
Percentage
Gain/Loss : |
0.0%
|
27.4%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Eli Lilly & Co |
LLY |
Former Officer |
2021-02-08 |
77,659 |
2021-02-08 |
2,151 |
Premium* |
|
Zai Lab Ltd |
ZLAB |
|
2024-05-13 |
31,684 |
2023-08-15 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
21 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
LLY |
Eli Lilly & Co |
SVP and CFO |
|
2018-01-29 |
4 |
A |
$87.60 |
$630,895 |
D/D |
7,202 |
23,029 |
0 |
- |
|
LLY |
Eli Lilly & Co |
SVP and CFO |
|
2018-03-16 |
4 |
AS |
$79.20 |
$237,600 |
D/D |
(3,000) |
20,029 |
0 |
- |
|
LLY |
Eli Lilly & Co |
SVP and CFO |
|
2019-02-04 |
4/A |
A |
$120.17 |
$1,196,292 |
D/D |
9,955 |
29,984 |
0 |
- |
|
LLY |
Eli Lilly & Co |
SVP and CFO |
|
2019-02-04 |
4 |
A |
$120.17 |
$1,196,172 |
D/D |
9,954 |
29,983 |
0 |
- |
|
LLY |
Eli Lilly & Co |
SVP and CFO |
|
2019-06-05 |
4 |
B |
$118.03 |
$50,281 |
D/D |
426 |
30,410 |
2.74 |
- |
|
LLY |
Eli Lilly & Co |
SVP and CFO |
|
2019-07-15 |
4 |
AB |
$108.47 |
$20,067 |
D/D |
185 |
30,595 |
0 |
- |
|
LLY |
Eli Lilly & Co |
SVP and CFO |
|
2019-10-25 |
4 |
B |
$107.59 |
$99,951 |
D/D |
929 |
31,524 |
2.74 |
- |
|
LLY |
Eli Lilly & Co |
SVP and CFO |
|
2020-02-11 |
4 |
A |
$144.25 |
$785,730 |
D/D |
5,447 |
36,971 |
0 |
- |
|
LLY |
Eli Lilly & Co |
SVP and CFO |
|
2020-10-01 |
4 |
D |
$148.02 |
$515,406 |
D/D |
(3,482) |
41,436 |
0 |
- |
|
LLY |
Eli Lilly & Co |
SVP and CFO |
|
2020-10-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,947 |
44,918 |
0 |
- |
|
LLY |
Eli Lilly & Co |
SVP and CFO |
|
2021-02-01 |
4 |
D |
$207.97 |
$1,757,762 |
D/D |
(8,452) |
52,250 |
0 |
- |
|
LLY |
Eli Lilly & Co |
SVP and CFO |
|
2021-02-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
19,266 |
60,702 |
0 |
- |
|
LLY |
Eli Lilly & Co |
Former Officer |
|
2021-02-08 |
4 |
A |
$205.77 |
$5,228,410 |
D/D |
25,409 |
77,659 |
0 |
- |
|
ZLAB |
Zai Lab Ltd |
See Remarks |
|
2023-08-15 |
4 |
D |
$24.52 |
$107,226 |
D/D |
(4,373) |
11,527 |
0 |
- |
|
ZLAB |
Zai Lab Ltd |
See Remarks |
|
2023-08-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
15,900 |
15,900 |
0 |
- |
|
ZLAB |
Zai Lab Ltd |
See Remarks |
|
2023-11-16 |
4 |
AB |
$26.93 |
$134,650 |
D/D |
5,000 |
16,527 |
0 |
% |
|
ZLAB |
Zai Lab Ltd |
See Remarks |
|
2023-12-14 |
4 |
AB |
$29.90 |
$119,600 |
D/D |
4,000 |
20,527 |
0 |
% |
|
ZLAB |
Zai Lab Ltd |
See Remarks |
|
2024-03-01 |
4 |
AB |
$20.83 |
$62,490 |
D/D |
3,000 |
23,527 |
0 |
% |
|
ZLAB |
Zai Lab Ltd |
See Remarks |
|
2024-04-03 |
4 |
OE |
$15.90 |
$113,606 |
D/D |
7,145 |
30,672 |
0 |
- |
|
ZLAB |
Zai Lab Ltd |
See Remarks |
|
2024-04-04 |
4 |
S |
$15.67 |
$31,158 |
D/D |
(1,988) |
28,684 |
0 |
% |
|
ZLAB |
Zai Lab Ltd |
See Remarks |
|
2024-05-13 |
4 |
AB |
$21.40 |
$64,200 |
D/D |
3,000 |
31,684 |
0 |
% |
|
21 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|